Atlas Trials

Dapagliflozin and Hydrochlorothiazide in Recurring Kidney Stone Patients

Clinical trial NCT05443932 · UNKNOWN

Trial details

NCT number
NCT05443932
Sponsor
Medical University of Vienna
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
UrolithiasisHyperoxaluria
Start date
2024-03-04
Primary completion
2024-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.